Fonadelpar is a PPARδ agonist, used in the research of neuroparalytic keratopathy.
Fonadelpar is a PPARδ agonist, used in the research of neuroparalytic keratopathy[1].
[1]. Kobayashi, et al. Therapeutic agent for neuroparalytic keratopathy containing benzisoxazol compound-?based PPARδ agonist. WO2016199871A1.
















